Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer

2714.1000 87.75 (3.34%)

NSE Mar 21, 2025 15:31 PM

32.29% Gain from 52W Low

Volume: 1.1M

High volume today

Ajanta Pharma Ltd.

01 Feb 2022

2714.10

3.34%

Ajanta Pharma (BUY): Strong revenue growth but margins contract

Buy: Ajanta Pharma Ltd.

Target

BOB Capital Markets Ltd.

Q3 revenue up 12% YoY spurred by branded formulations business in India and Africa; US sales down 14% QoQ to US$ 22mn

Ajanta Pharma Ltd.'s price crossed above 50Day SMA today